These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 7528361)
41. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. Miyata T; Hori O; Zhang J; Yan SD; Ferran L; Iida Y; Schmidt AM J Clin Invest; 1996 Sep; 98(5):1088-94. PubMed ID: 8787669 [TBL] [Abstract][Full Text] [Related]
43. Antiproteases and cells in the pathogenesis of beta(2)-microglobulin amyloidosis: role of alpha(2)-macroglobulin and macrophages. Argilés A; Mourad G; Gouin-Charnet A; Schmitt-Bernard CF Nephron; 2000 Sep; 86(1):1-11. PubMed ID: 10971148 [No Abstract] [Full Text] [Related]
44. Dialysis-related arthropathy and beta 2M amyloidosis. Gaucher A; Kessler M; Netter P Rev Rhum Engl Ed; 1995 Apr; 62(4):225-7. PubMed ID: 7606416 [No Abstract] [Full Text] [Related]
45. [The polyarticular and destructive form of amyloid arthropathy in dialysis patients. Apropos of a case]. Jarde O; Fardellone P; Brasseur T; Bellony R; Sebert JL; Vives P Rev Rhum Mal Osteoartic; 1989 Jun; 56(7):555-7. PubMed ID: 2667089 [No Abstract] [Full Text] [Related]
46. Dialysis amyloidosis: beta-2-microglobulin in the context of other amyloidogenic proteins. Gorevic PD; Munoz P Blood Purif; 1988; 6(2):132-44. PubMed ID: 3293617 [No Abstract] [Full Text] [Related]
48. [Studies on the interaction of human cationic trypsin with serum protease inhibitors (author's transl)]. Iwaki K; Ogawa M; Kitahara T; Tanaka S; Kosaki G Nihon Shokakibyo Gakkai Zasshi; 1982 Feb; 79(2):276-81. PubMed ID: 6178863 [No Abstract] [Full Text] [Related]
49. Role of macrophages in beta 2-microglobulin-related dialysis amyloidosis. Gejyo F; Maruyama H; Teramura T; Kazama J; Ei I; Arakawa M Contrib Nephrol; 1995; 112():97-104. PubMed ID: 7554998 [No Abstract] [Full Text] [Related]
50. Macromolecules that are colocalized with deposits of beta 2-microglobulin in hemodialysis-associated amyloidosis. Aruga E; Ozasa H; Teraoka S; Ota K Lab Invest; 1993 Aug; 69(2):223-30. PubMed ID: 8394479 [TBL] [Abstract][Full Text] [Related]
51. Dialysis related amyloidosis. Bardin T J Rheumatol; 1987 Aug; 14(4):647-9. PubMed ID: 3312600 [No Abstract] [Full Text] [Related]
53. Dialysis amyloidosis: clinical aspects and therapeutic approach. Brancaccio D; Cozzolino M; Gallieni M Nephrol Dial Transplant; 1996; 11 Suppl 3():102-5. PubMed ID: 8840323 [No Abstract] [Full Text] [Related]
54. C1Q complexes with beta-2-microglobulin and amyloid P-component in sera of patients with dialysis-associated amyloidosis. Hasegawa M; Kawashima S; Shikano M; Kojima K; Yanai T; Hassegawa H; Tomita M; Murakami K; Kawamura N; Katsumata H Nephron; 1995; 69(4):380-3. PubMed ID: 7777100 [TBL] [Abstract][Full Text] [Related]
55. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy]. Czyz W; Szepietowski T Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582 [TBL] [Abstract][Full Text] [Related]
57. Advanced glycation of beta 2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosis. Miyata T; Sprague SM Nephrol Dial Transplant; 1996; 11 Suppl 3():86-90. PubMed ID: 8840320 [No Abstract] [Full Text] [Related]